01—Abstract
Summary
Summary of the 8-K filed March 19, 2026. Cited figures are marked; the original filing is the authoritative source.
CVS Health Corporation (CVS) announced a significant addition to its Board of Directors with the election of John E.
Gallina, effective March 19, 2026. Mr. Gallina brings extensive financial expertise, having served as the former Executive Vice President and Chief Financial Officer of Elevance Health, Inc. (ELV) for over seven years. His nearly three-decade tenure at Elevance, coupled with prior experience in senior audit and accounting roles, positions him as a valuable asset to CVS Health's governance.
Importantly for investors, Mr. Gallina has been appointed to the Board's Audit Committee and has been designated an "audit committee financial expert." This appointment underscores CVS Health's commitment to robust financial oversight and compliance. His compensation as a non-employee director will align with the company's existing practices for its independent board members.
02—Key points
Key Highlights
- John E. Gallina elected to the CVS Health Board of Directors, effective March 19, 2026.
- Mr. Gallina is the former EVP and CFO of Elevance Health, Inc. (ELV).
- He brings nearly 30 years of financial and audit-related experience from Elevance.
- Gallina has been appointed to the Board's Audit Committee.
- He has been designated an "audit committee financial expert" by the SEC.
- Mr. Gallina has been determined to be an "independent" director by the Board.
- His compensation will be consistent with other non-employee directors.
03—Questions
Frequently Asked Questions
Who is John E. Gallina and what is his background?
John E. Gallina is a seasoned financial executive who has been elected to the CVS Health Board of Directors. He is the former Executive Vice President and Chief Financial Officer of Elevance Health, Inc. (ELV), where he served for nearly 30 years in various finance and audit roles. He is a certified public accountant and holds a bachelor's degree in business administration.
What is the significance of Mr. Gallina's appointment to the Audit Committee?
Mr. Gallina's appointment to the Audit Committee, along with his designation as an "audit committee financial expert," signals a strengthened focus on financial oversight and governance for CVS Health. This appointment is a positive indicator for investors concerned with financial reporting accuracy and internal controls.
How will Mr. Gallina be compensated for his role as a director?
Mr. Gallina's compensation for his service as a non-employee director will be consistent with that of the Company's other non-employee directors. This compensation will be prorated to reflect the start date of his service on the Board, as further detailed in CVS Health's annual proxy statement.
Is Mr. Gallina considered an independent director?
Yes, the CVS Health Board of Directors has determined that Mr. Gallina is "independent" under the Corporate Governance Rules of the New York Stock Exchange and the Company’s Corporate Governance Guidelines.
04—Continue